Molecular Formula | C19H14Br2O3 |
Molar Mass | 450.12 |
Density | 1.734±0.06 g/cm3(Predicted) |
Boling Point | 610.2±55.0 °C(Predicted) |
Use | Use 9-bromo-3-(2-bromoacetyl)-10, 11-dihydro-5h-dibenzo (C,G) CHROMEN-8(9h)-Ketone is an antiviral and Velpatasvir(V116000) intermediate. Velpatasvir is an NS5A inhibitor for patients with hepatitis c virus (HCV) infection. |
boiling point | 610.2±55.0 °C(Predicted) |
density | 1.734±0.06 g/cm3(Predicted) |
use |
9-bromo-3-(2-bromoacetyl)-10, 11-dihydro-5H-dibenzo (C,G) CHROMEN-8(9H)-one is an antiviral drug and Velpatasvir(V116000) intermediate. Velpatasvir is an NS5A inhibitor in patients with hepatitis C (HCV) infection. |
application | 9-bromo-3-(2-bromoacetyl)-10, 11-dihydro-5H-dibenzo (C,G) CHROMEN-8(9H)-one can be used as an intermediate in organic synthesis and pharmaceutical intermediates, mainly used in laboratory research and development processes and chemical and pharmaceutical synthesis processes. |
Use | 9-bromo-3-(2-bromoacetyl)-10, 11-dihydro-5H-dibenzo (C,G) CHROMEN-8(9H)-ketone is an antiviral drug and Velpatasvir(V116000) intermediate. Velpatasvir is an NS5A inhibitor in patients with hepatitis C (HCV) infection. |
application | 9-bromo-3-(2-bromoacetyl)-10, 11-dihydro-5H-dibenzo (C,G) CHROMEN-8(9H)-ketones can be used as organic synthesis intermediates and pharmaceutical intermediates, mainly used in laboratory research and development processes and chemical and pharmaceutical synthesis processes. |